Methallylescaline

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Methallylescaline
Methallylescaline.png
Names
IUPAC name
2-{3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethanamine
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
Properties
C14H21NO3
Molar mass 251.326 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

Methallylescaline (4-methylallyloxy-3,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug. It is also the 4-methyl analog of allylescaline. Methallylescaline was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 40–65 mg and the duration is listed as 12–16 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of methallylescaline.

Legal status[edit]

Allylescaline is illegal in Sweden as of 26 January 2016.[2]

See also[edit]

References[edit]

  1. ^ Methallylescaline entry in PiHKAL
  2. ^ "31 nya ämnen kan klassas som narkotika eller hälsofarlig vara" (in Swedish). Folkhälsomyndigheten. November 2015.